ArticleThe Malaysian journal of medical sciences : MJMS2022
Translation and Validation of American Diabetes Association Diabetes Risk Test: The Malay Version.
Article in The Malaysian journal of medical sciences : MJMS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 9 citations in OpenAlex.
- Can social media encourage diabetes self-screenings? A randomized controlled trial with Indonesian Facebook users.NPJ digital medicine · 2024Article
- A probabilistic computation framework to estimate the dawn phenomenon in type 2 diabetes using continuous glucose monitoring.Scientific reports · 2024Article
- Arabic version of the Australian type 2 diabetes risk assessment tool (AUSDRISK): translation and validation.BMC research notes · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early detection of high-risk people for type 2 diabetes mellitus (T2DM) using a simple, non-invasive and cost-effective assessment tool helps to identify and prevent members of the community from developing this disease. Therefore, this study aims to translate the American Diabetes Association (ADA) diabetes risk test for Malaysians and then evaluate its validity. Methods: This cross-sectional study was conducted between March 2019 and April 2019. The instrument underwent forward and backward translation according to Behling and Law's technique. Content validity was performed by two experts and face validity was conducted among 35 convenience samples from Kota Bharu, Kelantan. Both were analysed using content validity index and face validity index, respectively. Results: All respondents were Malay, and had attained tertiary education with a mean (standard deviation [SD]) age of 20.63 (2.80) years old and BMI of 30.45 (5.99). Among the respondents, 57.1%, 94.3% and 80% were female, single and having a household income below RM1,500, respectively. The Malay translated instrument achieved high I-content validity index (CVI) [0.5-1.0] and S-CVI/Ave [0.93] as well as high I-face validity index (FVI) [0.86-0.97] and S-FVI/Ave [0.91] for understandability, and high I-FVI [0.77-0.91] and S-FVI/Ave [0.85] for clarity. Conclusion: The Malay version of the ADA diabetes risk test was found to be a valid survey instrument to be used for the Malaysian adult population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.